Patent 9720005 was granted and assigned to Randox Laboratories on August, 2017 by the United States Patent and Trademark Office.
An immunoassay method for detecting and determining ‘NBOMe’ family designer drugs is described. Also described are components for use in implementing the method, namely, antibodies, detection agents, solid state devices and kits as well as immunogens used to raise the antibodies.